Remedo

Fremont, United States Founded: 2016 • Age: 10 yrs Minicorn
AI-driven marketing platform is utilized for healthcare providers.

About Remedo

Remedo is a Healthcare company based in Fremont (United States) founded in 2016 by Ruchir Mehra and Richeek Arya. AI-driven marketing platform is utilized for healthcare providers. Remedo has raised $2.08 million across 5 funding rounds from investors including Angel List, Whiteboard Capital and SucSEED Indovation. The company has 59 employees. Remedo was last valued at $4.79 million in February 2022. Its website remedo.io draws about 11 thousand monthly visits. Its Indian entity Remedo Clinitech Private Limited reported revenue of β‚Ή2.71 Cr. Remedo offers products and services including Marketing Services, Web Design Services, AI Chatbot, and Reputation Management. Its focus areas include HealthTech, Healthcare IT, Horizontal and Marketing Solutions.

Company details

Remedo was founded in 2016 and is headquartered in Fremont, United States. An AI-powered marketing platform is operated specifically for the healthcare industry. Insights into marketing performance are delivered through a dashboard, enabling optimization of website visibility, search rankings, and patient leads. Services such as website creation, Google ads management, and SEO are provided to support healthcare providers.

  • Headquarters Fremont, United States
  • Employees 59
  • Founders Ruchir Mehra, Richeek Arya
  • Stage Minicorn
  • Sectors
    Healthcare
  • Email
    β€’β€’β€’β€’β€’β€’β€’β€’
  • Website remedo.io
  • Social LinkedIn X Facebook Instagram
  • Legal Name Remedo Clinitech Private Limited
  • Date of Incorporation 24 Jun, 2016
  • Jurisdiction Mumbai, Maharashtra, India
Key Metrics
  • Indian entity revenue
    ₹2.71 Cr

    FY 2024 · +27% YoY

  • Indian entity net loss
    -₹3.12 Cr

    FY 2024 · -115% margin

  • Indian entity EBITDA
    -₹1.44 Cr

    FY 2024 · -53% margin

  • Total Equity Funding
    $2.08M (USD)

    in 5 rounds

  • Latest Funding Round
    $636.99K (USD), Seed

    Nov 2022

  • Investors
    Angel List

    & 64 more

  • Employee Count
    59

Products & Services of Remedo

Remedo offers a comprehensive portfolio of products and services, including Marketing Services, Web Design Services, AI Chatbot, and Reputation Management.

Marketing Services
Digital Marketing

AI-driven strategies to attract and convert patients

Web Design Services
Website Development

Custom websites for improved patient conversion

AI Chatbot
Patient Engagement

24/7 tool for answering queries and managing leads

Reputation Management
Online Management

Services to enhance reviews and online ratings

Funding Insights of Remedo

Remedo has successfully raised a total of $2.08M across 5 strategic funding rounds. The most recent funding activity was a Seed round of $636.99 thousand completed in November 2022. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

  • Total Funding $2.08M
  • Total Rounds 5
  • Last Round Seed β€” $636,986
  • First Round $153,450

    (Mar 2018)

  • Investors Count 65

All 5 funding rounds of Remedo with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.

DateAmountTransaction NameValuationLead InvestorsInvestors
Nov 2022$636,986Seed––
Feb 2022$793,789Seed$4.79MAngel List, SucSEED Indovation
Jun 2020$86,001Seed$3.27MInflection Point Ventures
Nov 2019$405,812Seed$β€’β€’β€’β€’β€’Angel List
Mar 2018$153,450Angel Round$β€’β€’β€’β€’β€’Madhu Bansal, Pradeep Mehra
–
Valuation history
DateValuationStage
Feb 2022$4.79Mβ€’β€’β€’β€’β€’β€’β€’β€’
Jun 2020$3.27Mβ€’β€’β€’β€’β€’β€’β€’β€’
Nov 2019$β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’
Mar 2018$β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’
Premium access

Full valuation and stage history of Remedo

Every valuation point, the growth-stage changes (minicorn, soonicorn, unicorn) and the dates behind them require an active premium plan.

  • All valuation points
  • Stage changes
  • Dates
  • Exports

Verified entity values are shown only after access is granted.

Last known valuation $4.79M (Feb 2022). 65 investors in total: 9 institutional and 56 angel.

Investors in Remedo

Remedo has secured backing from 65 investors, including venture fund, angel, and institutional investors. Prominent investors backing the company include Angel List, Whiteboard Capital and SucSEED Indovation.

All
Venture Fund
Institutional
Angel
InvestorDescriptionFounded YearDomainLocation
Investment in early to growth-stage tech startups across various sectors.
2016sucseed-indovation.comHyderabad, India
Investment support is provided to startups by Whiteboard Capital.
2017whiteboardcap.comMumbai, India
Investments are made in early-stage companies by Titan Capital.
titancapital.vcGurugram, India
Seed-stage investments in diverse sectors are targeted by the firm.
Bengaluru, India
Investments are made in early-stage tech startups across sectors.
ipventures.inGurugram, India
Smile Group is engaged in investing, building, and partnering with disruptive founders across Asia.
smile.groupGurugram, India
Alternative investment platform for startups and investors is operated.
2010angellist.comSan Francisco, United States
Venture capital investments are managed by Nakrani Ventures.
Startup jobs are connected to seekers via an online platform.
angel.coSan Francisco, United States

Shashvat Nakrani

Co-founder of BharatPe, prominent angel investor in Indian startups
unknown_22ed4c26a85547da8
Premium access

Investor details for Remedo

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

Board of directors of Remedo Clinitech Private Limited (Remedo)

Remedo Clinitech Private Limited is the primary company behind Remedo. The board of Remedo Clinitech Private Limited currently have 4 directors; the longest-serving is Ruchir Mehra, appointed in 2016.

DirectorDesignationAppointedTenureEntity
Ruchir Mehra
DIN 07505278
Director24 Jun 201610 yrs 4 moRemedo Clinitech Private Limited
Harsh Vardhan Bansal
DIN 07505270
Director24 Jun 201610 yrs 4 moRemedo Clinitech Private Limited
Richeek Arya
DIN 07770347
Whole-time director22 Mar 20179 yrs 7 moRemedo Clinitech Private Limited
Pradeep Mehra
DIN 08551524
Director25 Sep 20197 yrs 1 moRemedo Clinitech Private Limited

People of Remedo

2 people are tracked at Remedo (2 in leadership); the tracked headcount is 59.

NameRoleGroup
Co-FounderLeadership
Co-FounderLeadership
Premium access

Complete people profiles for Remedo

Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.

  • Full employee list
  • Team structure
  • Board tenure
  • Professional contacts

Verified entity values are shown only after access is granted.

Financials of Remedo

Figures of Remedo Clinitech Private Limited, the primary company behind Remedo, for FY 2024. Revenue was ₹2.71 Cr (+27% year on year). Net loss was -₹3.12 Cr (-115% margin). EBITDA was -₹1.44 Cr (-53% margin). Revenue has grown at a compounded annual rate of +36% over three years and +84% over five years.

  • ₹2.71 CrRevenue · FY 2024 · +27% YoY
  • -₹3.12 CrNet loss · -115% margin
  • -₹1.44 CrEBITDA · -53% margin
  • ₹16.3 LakhPaid-up capital
  • 59Employees (provident fund records)
  • +36%Revenue CAGR, 3 years
  • +84%Revenue CAGR, 5 years

Balance sheet, profit and loss, cash flow and ratios of Remedo Clinitech Private Limited are on its company page.

Premium access

Detailed financial statements for Remedo

Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.

  • Statement rows
  • Financial ratios
  • Five-year trends
  • Downloads

Verified entity values are shown only after access is granted.

Timeline of Remedo

4 dated milestones of Remedo across 6 years, from founding to its latest funding, stage changes and deals.

  1. Founded Remedo is founded.
  2. Funding First funding round of $153K.
  3. Milestone Reaches Minicorn status.
  4. Funding Latest funding round, Seed, of $637K.

Web traffic of Remedo

The website of Remedo (remedo.io) receives about 11.5K visits a month.

  • Monthly visits
    11.5K

    ▲ 83.1% vs previous month

Similar websites

Websites whose visitors overlap most with Remedo. Affinity shows how closely the audiences match.

WebsiteDomainAudience affinityMonthly visitsGlobal rankProfile
remedoapp.com
remedoapp.com
100%
#912,379–

Top companies in Clinical IT & Data Platforms

3 companies that operate in the same segment as Remedo (Clinical IT & Data Platforms) in United States, ranked by their profile score on The Company Check.

CompanyDescriptionFoundedLocationTotal fundingRevenueEmployees
Employee health benefits are facilitated via a cloud-based platform.
2007Plymouth Meeting, Pennsylvania, United StatesUSD 228.3 M
Healthcare appointments are booked online via Zocdoc's platform.
2007New York, New York, United StatesUSD 425.97 MUSD 4.66 M1,365
Virtual physical therapy and digital pain care solutions are provided.
2015San Francisco, California, United StatesUSD 854.44 M1,746
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Related news about Remedo

Premium access

Complete news archive for Remedo

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Remedo

Remedo was founded in 2016 and raised its 1st funding round 2 years after it was founded.

Remedo is headquartered in Fremont, United States. It is registered at Fremont, California, United States.

Remedo is a funded company, having raised a total of $2.08M across 5 funding rounds to date. The company's 1st funding round was a Angel Round of $153.45K, raised on Mar 2018.

Remedo has 59 employees.

The primary company behind Remedo, Remedo Clinitech Private Limited, reported revenue of β‚Ή2.71 Cr for FY 2024, up 27% year on year.

Remedo was founded in 2016 and is headquartered in Fremont, United States. An AI-powered marketing platform is operated specifically for the healthcare industry. Insights into marketing performance are delivered through a dashboard, enabling optimization of website visibility, search rankings, and patient leads. Services such as website creation, Google ads management, and SEO are provided to support healthcare providers.

Remedo offers Marketing Services, Web Design Services, AI Chatbot, and Reputation Management.

Remedo has 65 investors. Key investors include Angel List, Whiteboard Capital, SucSEED Indovation, Titan Capital, and Shashvat Nakrani.

The valuation of Remedo is $4.79M as of Feb 2022.

Remedo operates through Remedo Clinitech Private Limited.

The legal entities of Remedo currently have 4 directors, including Ruchir Mehra, Harsh Vardhan Bansal, Richeek Arya and others.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available